Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, 770👍, 0💬
Popular Posts:
How to use GraphQL API, api.datacite.org/graphql ?GraphQL API, api.datacite.org/graphql ,allows you ...
How to represent DOI content in Citeproc JSON format? Citeproc JSON is also called as CSL-JSON Schem...
What is PaperPanda - Chrome Extension? PaperPanda is a Chrome Extension that helps you download rese...
What is DOI (Digital Object Identifier)? DOI (Digital Object Identifier) is a unique, persistent ide...
How to download scientif paper with LibGen (Library Genesis)? LibGen (Library Genesis) is a file-sha...